Manufacturer
Pfizer NDC Codes
Finished products listed with the FDA under labeler names that contain “Pfizer”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Retacritepoetin alfa-epbx | Epoetin 2000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1305 |
| Retacritepoetin alfa-epbx | Epoetin 3000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1306 |
| Retacritepoetin alfa-epbx | Epoetin 4000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1307 |
| Retacritepoetin alfa-epbx | Epoetin 10000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1308 |
| Retacritepoetin alfa-epbx | Epoetin 40000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1309 |
| Retacritepoetin alfa-epbx | Epoetin 20000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1311 |
| Retacritepoetin alfa-epbx | Epoetin 10000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1318 |
| Revatiosildenafil citrate | Sildenafil citrate 20 mg/1 | Tablet, Film coatedOral | PFIZER LABORATORIES DIV PFIZER INC | 0069-4190 |
| Ruxiencerituximab-pvvr | Rituximab 100 mg/10mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0238 |
| Ruxiencerituximab-pvvr | Rituximab 500 mg/50mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0249 |
| Silvadenesilver sulfadiazine | Silver sulfadiazine 10 mg/g | CreamTopical | Pfizer Laboratories Div Pfizer Inc | 61570-131 |
| Sutentsunitinib malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0550 |
| Sutentsunitinib malate | Sunitinib malate 25 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0770 |
| Sutentsunitinib malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0830 |
| Sutentsunitinib malate | Sunitinib malate 50 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0980 |
| Synarelnafarelin acetate | Nafarelin acetate 2 mg/mL | Spray, MeteredNasal | Pfizer Laboratories Div Pfizer Inc | 0025-0166 |
| Talzennatalazoparib | Talazoparib tosylate .1 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0252 |
| Talzennatalazoparib | Talazoparib tosylate .25 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0296 |
| Talzennatalazoparib | Talazoparib tosylate .25 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0353 |
| Talzennatalazoparib | Talazoparib tosylate .35 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0454 |
| Talzennatalazoparib | Talazoparib tosylate .5 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0546 |
| Talzennatalazoparib | Talazoparib tosylate .75 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0655 |
| Talzennatalazoparib | Talazoparib tosylate 1 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-0757 |
| Talzennatalazoparib | Talazoparib tosylate 1 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-1195 |
| Talzennatalazoparib | Talazoparib tosylate .5 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-1501 |